Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William S Sly

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Missouri Medicine|May 4, 2004
Enzyme replacement therapy for lysosomal storage disorders: successful transition from concept to clinical practiceWilliam S Sly
Sub-Cellular Biochemistry|October 23, 2013
Membrane associated carbonic anhydrase IV (CA IV): a personal and historical perspectiveAbdul Waheed, William S Sly
EMBO Molecular Medicine|May 9, 2013
The final frontier -- crossing the blood-brain barrierWilliam S Sly, Carole Vogler
Gene|April 24, 2017
Carbonic anhydrase XII functions in health and diseaseAbdul Waheed, William S Sly
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2002
Brain-directed gene therapy for lysosomal storage disease: going well beyond the blood- brain barrierWilliam S Sly, Carole Vogler
Annual Review of Physiology|February 5, 2002
Mechanisms of iron accumulation in hereditary hemochromatosisRobert E Fleming, William S Sly
Missouri Medicine|October 17, 2018
The Nobel Path of Cellular ProteinsJoel C Eissenberg, William S Sly
Rejuvenation Research|March 30, 2010
New strategies for enzyme replacement therapy for lysosomal storage diseasesJeffrey H Grubb, Carole Vogler, William S Sly
Genetic Testing|March 31, 2007
PCR-based restriction fragment length polymorphism and haplotype of the most common mutation L176F in the beta-glucuronidase geneM Rafiq Islam, Gul N Shah, William S Sly
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2004
Chemical chaperones protect from effects of apoptosis-inducing mutation in carbonic anhydrase IV identified in retinitis pigmentosa 17Giuseppe Bonapace, Abdul Waheed, Gul N Shah, et al.
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Missouri Medicine|May 4, 2004
Enzyme replacement therapy for lysosomal storage disorders: successful transition from concept to clinical practiceWilliam S Sly
Sub-Cellular Biochemistry|October 23, 2013
Membrane associated carbonic anhydrase IV (CA IV): a personal and historical perspectiveAbdul Waheed, William S Sly
EMBO Molecular Medicine|May 9, 2013
The final frontier -- crossing the blood-brain barrierWilliam S Sly, Carole Vogler
Gene|April 24, 2017
Carbonic anhydrase XII functions in health and diseaseAbdul Waheed, William S Sly
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2002
Brain-directed gene therapy for lysosomal storage disease: going well beyond the blood- brain barrierWilliam S Sly, Carole Vogler
Annual Review of Physiology|February 5, 2002
Mechanisms of iron accumulation in hereditary hemochromatosisRobert E Fleming, William S Sly
Missouri Medicine|October 17, 2018
The Nobel Path of Cellular ProteinsJoel C Eissenberg, William S Sly
Rejuvenation Research|March 30, 2010
New strategies for enzyme replacement therapy for lysosomal storage diseasesJeffrey H Grubb, Carole Vogler, William S Sly
Genetic Testing|March 31, 2007
PCR-based restriction fragment length polymorphism and haplotype of the most common mutation L176F in the beta-glucuronidase geneM Rafiq Islam, Gul N Shah, William S Sly
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2004
Chemical chaperones protect from effects of apoptosis-inducing mutation in carbonic anhydrase IV identified in retinitis pigmentosa 17Giuseppe Bonapace, Abdul Waheed, Gul N Shah, et al.
Pageof 13